Article Details
Retrieved on: 2022-01-15 16:06:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Zacks Investment Research cut shares of Aspira Women's Health from a "hold" rating to a "sell" rating in a research note on Friday.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here